San Francisco, 31 December 2018: The Report Heart Attack Diagnostics Market Analysis by Test type (Electrocardiogram, Blood
Tests (Troponin, CK-MB), Echocardiogram), by Region (U.S., Canada, UK, Germany,
China, India, Brazil, Mexico, South Africa, Middle East), and Segment Forecasts
to 2024
The heart attack diagnostics market is expected to reach USD 15.4 billion by 2024, according
to a new report by Grand View Research, Inc. The heart attack diagnostics
market is anticipated to witness a lucrative growth during the forecast period
from2016 to 2024. From 2001 to 2011, age-standardized, heart attack incidence
rates have significantly decreased worldwide. However, the overall risk factors
and the disease burden remains large, thereby rendering the heart attack
diagnostic sectors a profitable growth prospect. This growth is attributed to a
majority of factors, such as high prevalence of coronary heart diseases,
increased tobacco smoking, and obesity, enhanced adoption of unhealthy diet is
resulting in a high cholesterol incidence in individuals, particularly in the
rising geriatric population. However, the low Medicare reimbursement provided
for the mobile cardiac outpatient telemetry electrocardiogram (ECG) and the
progressively declining heart attack incidence rates are expected to hamper the
market growth.
The heart attack diagnostics market has been classified
by product into electrocardiogram, which measures the electrical activity of
the heart; echocardiogram, a form of ultrasound test that provides images of
the heart; blood tests that measure the expression of certain proteins in
excess, such as troponin levels, and cardiac enzymes; and other diagnostic
products. The ECG segment is expected to witness a significant growth rate in
developing countries, owing to the technological advances coupled with
increasing applications of ECG. Although, the increasing demand for cost
effective, rapid blood tests such as troponin and Creatine Kinase MB Isoenzyme
(CK-MB) is likely to acquire major market share in the near future. The key
countries landscape included in the report are U.S., Canada, Germany, UK,
China, India, Brazil, Mexico, South Africa, and Middle East. The Asia Pacific region is anticipated to
be the fastest growing region during the forecast period. On the other hand,
North America is estimated to dominate the global heart attack diagnostics
market.
Access Research Report of Heart Attack Diagnostics Market @ www.grandviewresearch.com/industry-analysis/heart-attack-diagnostics-market
Further key findings from the study suggest:
· North America is estimated to dominate the
global heart attack diagnostics market. The increasing awareness about heart
attacks, its causative and risk factors, and enhanced uptake and acceptance of
technologically advanced diagnostics is expected to contribute to the market
growth.
· The Asia Pacific region is expected to be
the fastest growing region during the forecast period. to The reason being the
considerably large burden of heart diseases in certain developing regions, such
as in India, where 2.4 million people die annually due to heart diseases. As a
result of the soaring incidences of heart diseases, an urgent requirement to
undertake awareness measures and incorporate advanced diagnostics is expected
to fuel the market growth.
· The troponin blood test type is the largest
grossing segment and is expected to capture the largest share in 2015,
especially in developing countries including Brazil, China, and India. Its
applications as a cardiac monitoring device and its indispensable use as a
heart attack diagnostic tool will be a contributing factor supporting the
market growth. The industry comprises of several local as well as global
players. Some of the major players of this industry include Siemens Healthcare
GmbH, Schiller AG, GE Healthcare, and Hitachi Medical Systems.
Browse more reports of this category by Grand View
Research at: www.grandviewresearch.com/industry/clinical-diagnostics
Grand View Research has segmented the heart attack
diagnostics market on the basis of product and region:
Heart Attack Diagnostics Test Type Outlook (Revenue,
USD Million, 2013 - 2024)
·
Electrocardiogram (ECG)
·
Blood tests
·
Others
Heart Attack Diagnostics Regional
Outlook (Revenue, USD Million, 2013 - 2024)
·
North America
·
Europe
·
Asia Pacific
·
Latin America
·
MEA
Access Press Release of
Heart Attack Diagnostics Market@ www.grandviewresearch.com/press-release/global-heart-attack-diagnostics-market
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com
